Table of Contents
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-Q/A10-Q
 
 
 
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 20212022
OR
 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
                    
to
                    
 
 
Khosla Ventures Acquisition Co.
(Exact name of registrant as specified in its charter)
 
 
 
Delaware
 
001-40131
 
85-1488707
(State or other jurisdiction
of
incorporation)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
2128 Sand Hill Road
  
2128 Sand Hill Road
Menlo Park, California
 
94025
(Address of Principal Executive Offices)
 
(Zip Code)
(650)
376-8500
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange
on which registered
Class A common stock, par value $0.0001
per share
 
KVSA
 
The NASDAQ Stock Market LLC
 
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☐☒    No  ☒☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer
 
☐
  
Accelerated filer
 
☐
    
Non-accelerated
filer		 ☒  Smaller reporting company ☒
    
Emerging growth company ☒     
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).    Yes  ☒    No  ☐
As of September May
713,
, 2021,2022, 35,490,000 shares of Class A common stock, par value $0.0001 per share, 5,000,000 shares of Class B common stock, par value $0.0001 per share, and 5,000,000 shares of Class K common stock, par value $0.0001 per share were issued and outstanding, respectively.
 
 
 
Table of Contents
EXPLANATORY NOTE
Khosla Ventures Acquisition Corp. (the “Company,” “we,” “us” or “our”) is filing this Amendment No. 2 to its Quarterly Report on Form
10-Q/A
for the quarterly period ended March 31, 2021 (this “Quarterly Report”) to amend and restate certain terms in its Quarterly Report on Form
10-Q
for the quarterly period ended March 31, 2021 originally filed with the Securities and Exchange Commission (the “SEC”) on May 25, 2021 (the “Original Quarterly Report”).
Background of Restatement
Subsequent to filing of its Form
10-Q,
the Company identified errors in its historical financial statements related to the accounting for the Class A common stock and the Class K Founder Shares. Because the Class A common stock issued in the Initial Public Offering can be redeemed or become redeemable subject to the occurrence of future events considered outside of the Company’s control, the Company should have classified all of these redeemable shares in temporary equity and remeasured these redeemable shares to their redemption value (i.e., $10.00 per share) as of the end of the first reporting period after the date of the Company’s Initial Public Offering. The Company also concluded that it incorrectly accounted for the Class K Founder Shares as permanent equity versus a derivative liability and incorrectly accounted for certain items on the cash flow statement.
As a result, the Company’s management, together with the Audit Committee, determined on August 31, 2021, that the Company’s financial statements and other financial data as of and for the period from January 15, 2021 (inception) through March 31, 2021 included in the Company’s Quarterly Report on Form
10-Q
for the period ended March 31, 2021 should be restated in the Form
10-Q/A
as a result of these errors. These restatements result in
non-cash,
non-operating
financial statement corrections and have no impact on the Company’s current or previously reported cash position.
The financial information that has been previously filed or otherwise reported for this period is superseded by the information in this Form
10-Q/A,
and the financial statements and related financial information contained in the Original Quarterly Report should no longer be relied upon. On September 1, 2021, the Company filed a report on Form
8-K
disclosing the
non-reliance
on the financial statements included in the Original Quarterly Report.
Internal Control Considerations
In connection with the restatement, management has
re-evaluated
the effectiveness of the Company’s disclosure controls and procedures and internal control over financial reporting as of March 31, 2021. The Company’s management has concluded that in light of the errors described above, and the filing of the Form
10-Q,
that material weaknesses exist in the Company’s internal control over financial reporting and that the Company’s disclosure controls and procedures were not effective. Management plans to enhance the system of evaluating and implementing the accounting standards that apply to our financial statements, including enhanced training of our personnel and increased communication among our personnel and third-party professionals with whom we consult regarding application of complex accounting transactions. For a discussion of management’s consideration of our disclosure controls and procedures, internal controls over financial reporting, and the material weaknesses identified, see Part I, Item 4, “Controls and Procedures” of this Form
10-Q/A.
Table of Contents
KHOSLA VENTURES ACQUISITION CO.
Quarterly Report
on Form
10-Q
Table of Contents
Page No.
PART I. FINANCIAL INFORMATION
1
Item 1.
Financial Statements
1
Unaudited Condensed Balance Sheet as of March 31, 2021 (Restated)
1
Unaudited Condensed Statement of Operations for the period from January 15, 2021 (inception) through March 31, 2021 (Restated)
2
Unaudited Condensed Statement of Common Stock Subject to Possible Redemption and Changes in Stockholders’ Deficit for the period from January 15, 2021 (inception) through March 31, 2021 (Restated)
   3 
Unaudited Condensed Statement of Cash Flows for the period from January 15, 2021 (inception) through March 31, 2021 (Restated)Item 1. Financial Statements
   43 
Notes to Unaudited Condensed Financial Statements
5
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
   1819 
Special Note Regarding Forward-Looking Statements
   19
Item 3.
Overview
  19
QuantitativeResults of Operations and Qualitative Disclosures About Market RiskKnown Trends or Future Events
20
Liquidity and Capital Resources
20
Contractual Obligations
21
Critical Accounting Policies
21
Class K Founder Shares Derivative Liabilities
21
Recent Accounting Standards
   22 
Item 4.
ControlsItem 3. Quantitative and ProceduresQualitative Disclosures About Market Risk
   22 
PART II. OTHER INFORMATION22
Item 1.
Legal ProceedingsItem 4. Controls and Procedures
   22 
Item 1A.
Risk FactorsPART II-OTHER INFORMATION
   23 
Item 2.
Unregistered Sales of Equity Securities and Use of ProceedsItem 1. Legal Proceedings.
   23 
Item 3.
Defaults Upon Senior SecuritiesItem 1A. Risk Factors.
   23 
Item 4.
Mine Safety DisclosuresItem 2. Unregistered Sales of Equity Securities and Use of Proceeds.
   23 
Item 5.
Other InformationItem 3. Defaults Upon Senior Securities.
   23 
Item 6.
ExhibitsItem 4. Mine Safety Disclosures.
   23 
SIGNATURESItem 5. Other Information.
   23 
Item 6. Exhibits
23
SIGNATURES
25
Table of Contents
PART I. - FINANCIAL INFORMATION
Item 1. - Financial Statements
KHOSLA VENTURES ACQUISITION CO.
CONDENSED BALANCE SHEET
As of March 31, 2021 (Unaudited)
(As Restated)SHEETS
 
ASSETS
     
Cash and cash equivalents
  $1,546,860 
Prepaid expenses
   665,794 
Due from related party
   25,000 
   
 
 
 
Total current assets
   2,237,654 
Marketable securities held in Trust Account
   345,000,000 
Other assets
   613,040 
   
 
 
 
Total assets
  $347,850,694 
   
 
 
 
LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION, AND STOCKHOLDERS’ DEFICIT
     
Current liabilities:
     
Accounts payable
  $115,675 
Franchise tax payable
   50,000 
Accrued expenses
   541,237 
Due to related party
   600 
   
 
 
 
Total current liabilities
   707,512 
Deferred underwriting fees payable
   12,075,000 
Class K Founder Shares derivative liabilities
   3,150,000 
   
 
 
 
Total liabilities
   15,932,512 
   
 
 
 
Commitments and Contingencies (Note 6)
  0  
Class A common stock subject to possible redemption, 34,500,000 shares at $10.00 redemption value
   345,000,000 
Stockholders’ Deficit
     
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; 0ne issued and outstanding
   —   
Class A common stock, $0.0001 par value; 200,000,000 shares authorized; 990,000 issued and outstanding (excluding 34,500,000 shares subject to possible redemption)
   99 
Class B common stock, $0.0001 par value; 30,000,000 shares authorized; 5,000,000 shares issued and outstanding
   500 
Additional
paid-in
capital
   0   
Accumulated deficit
   (13,082,417) 
   
 
 
 
Total stockholders’ deficit
   (13,081,818) 
   
 
 
 
Total Liabilities, Common Stock Subject to Possible Redemption, and Stockholders’ Deficit
  
$
347,850,694
 
   
 
 
 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements.
1
Table of Contents
KHOSLA VENTURES ACQUISITION CO.
CONDENSED STATEMENT OF OPERATIONS
FOR THE PERIOD FROM JANUARY 15, 2021
(INCEPTION) THROUGH MARCH 31, 2021
(Unaudited)
(As Restated)
Formation costs
  $30,000 
General and administrative expenses
   116,558 
Franchise tax expense
   50,000 
   
 
 
 
Loss from operations
   (196,558) 
Financing expenses on derivative classified instrument
   (12,137,500) 
Change in fair value of derivative liabilities
   9,000,000 
   
 
 
 
Loss before income tax expense
   (3,334,058) 
Net loss
  
$
(3,334,058
) 
   
 
 
 
Weighted average shares outstanding of Class A common stock subject to possible redemption, basic and diluted
  
 
11,040,000
 
   
 
 
 
Basic and diluted net loss per share, Class A common stock subject to possible redemption
  
$
(0.20
) 
   
 
 
 
Weighted average shares outstanding of Class A
non-redeemable
common stock, basic and diluted
  
 
316,800
 
   
 
 
 
Basic and diluted net loss per share, Class A non-redeemable common stock
  
$
(0.20
) 
   
 
 
 
Weighted average shares outstanding Class B
non-redeemable
common stock, basic and diluted
  
 
5,000,000
 
   
 
 
 
Basic and diluted net loss per common stock, Class B
  
$
(0.20
) 
   
 
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements.
2
Table of Contents
KHOSLA VENTURES ACQUISITION CO.
CONDENSED STATEMENT OF CHANGES IN COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND
STOCKHOLDERS’ DEFICIT
FOR THE PERIOD FROM JANUARY 15, 2021 (INCEPTION) THROUGH MARCH 31, 2021
(Unaudited)
(As Restated)
   
Common Stock Subject to Possible Redemption
       
Common Stock
           
   
Class A
       
Class A
   
Class B
           
   
Shares
   
Amount
       
Shares
   
Amount
   
Shares
   
Amount
   
Additional
Paid-In

Capital
  
Accumulated
Deficit
  
Total
Stockholders’
Deficit
 
Balance as of January 15, 2021 (inception)
   —     $—         0     $0—      0     $0—     $0—    $0—    $0—   
Issuance of common stock to Sponsor
   —      —         —      —      5,000,000    500    12,000   —     12,500 
Sale of Public Shares, net of $19,660,260 issuance costs
   34,500,000    325,339,740       0      0      —      —      0     —     0   
Sale of Private Placement Shares
   —      —         990,000    99    —      —      9,899,901   —     9,900,000 
Accretion of Class A Common Stock to redemption value
   —      19,660,260       —      —      —      —      (9,911,901)   (9,748,359)   (19,660,260) 
Net loss
   —      —         —      —      —      —      —     (3,334,058)   (3,334,058) 
   
 
 
   
 
 
      
 
 
   
 
 
   
 
 
   
 
 
   
 
 
  
 
 
  
 
 
 
Balance as of March 31, 2021
  
 
34,500,000
 
  
$
345,000,000
 
     
 
990,000
 
  
$
99
 
  
 
5,000,000
 
  
$
500
 
  
$
0  
 
 
$
(13,082,417
) 
 
$
(13,081,818
) 
   
 
 
   
 
 
      
 
 
   
 
 
   
 
 
   
 
 
   
 
 
  
 
 
  
 
 
 
   
MARCH 31, 2022
(Unaudited)
  
DECEMBER 31, 2021
 
ASSETS
         
Cash
  $22,668  $202,245 
Prepaid expenses
   657,731   663,974 
   
 
 
  
 
 
 
Total current assets
   680,399   866,219 
Marketable securities held in Trust Account
   345,045,187   345,017,029 
Other
non-current
assets
   —     112,785 
   
 
 
  
 
 
 
Total Assets
  
$
345,725,586
 
 
$
345,996,033
 
   
 
 
  
 
 
 
          
LIABILITIES, COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION, AND STOCKHOLDERS’ DEFICIT
         
Current liabilities:
         
Accounts payable
  $168,288  $189,136 
Due to related party
   78,667   600 
Franchise tax payable
   244,071   200,000 
Accrued expenses
   3,836,767   3,815,467 
   
 
 
  
 
 
 
Total current liabilities
   4,327,793   4,205,203 
Deferred underwriting fees payable
   12,075,000   12,075,000 
Class K Founder Shares derivative liabilities
   —     150,000 
   
 
 
  
 
 
 
Total liabilities
   16,402,793   16,430,203 
   
 
 
  
 
 
 
Commitments and Contingencies (Note 5)
0   0   
Class A common stock subject to possible redemption, 34,500,000 shares at $10.00 per share
   345,045,187   345,017,029 
Stockholders’ deficit
         
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; NaN issued
and
outstanding
   0  —   0  — 
Class A common stock, $0.0001 par value; 200,000,000 shares authorized; 990,000 issued
and
outstanding (excluding 34,500,000 shares subject to possible redemption)
   99   99 
Class B common stock, $0.0001 par value; 30,000,000 shares authorized; 5,000,000 shares issued and outstanding
   500   500 
Additional
paid-in
capital
   —     0—   
Accumulated deficit
   (15,722,993)   (15,451,798) 
   
 
 
  
 
 
 
Total stockholders’ deficit
   (15,722,394)   (15,451,199) 
   
 
 
  
 
 
 
Total Liabilities, Common Stock Subject to Possible Redemption, and Stockholders’ Deficit
  
$
345,725,586
 
 
$
345,996,033
 
   
 
 
  
 
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
3
Table of Contents
KHOSLA VENTURES ACQUISITION CO.
CONDENSED STATEMENTSTATEMENTS OF CASH FLOWSOPERATIONS
(Unaudited)
   
For The Three
Months Ended
March 31, 2022
  
For The Period From
January 15, 2021
(Inception) Through
March 31, 2021
 
Formation costs
  $—    $30,000 
General and administrative expenses
   371,195   116,558 
Franchise tax expenses
   50,000   50,000 
   
 
 
  
 
 
 
Loss from operations
   (421,195)   (196,558) 
Financing expenses on derivative classified instrument
   —     (12,137,500) 
Change in fair value of derivative liabilities
   150,000   9,000,000 
Gain on marketable securities (net), dividends and interest, held in Trust Account
   28,158   —   
   
 
 
  
 
 
 
Net loss
  $(243,037)  $(3,334,058) 
   
 
 
  
 
 
 
Weighted average shares outstanding of Class A common stock subject to possible redemption, basic and diluted
   34,500,000   11,040,000 
Basic and diluted net loss per share, Class A subject to possible redemption
  
$
(0.01
) 
 
$
(0.25
)
Weighted average shares outstanding of Class A
non-redeemable
common stock, basic and diluted
   990,000   316,800 
Basic and diluted net loss per share, Class A
non-redeemable
common stock
  
$
(0.01
) 
 
$
(0.25
)
Weighted average shares outstanding of Class B
non-redeemable
common stock, basic and diluted
   5,000,000   5,000,000 
Basic and diluted net loss per share, Class B
non-redeemable
common stock
  
$
(0.01
) 
 
$
(0.09
) 
The accompanying notes are an integral part of these unaudited condensed financial statements.
4
KHOSLA VENTURES ACQUISITION CO.
CONDENSED STATEMENTS OF CHANGES IN COMMON STOCK SUBJECT TO POSSIBLE
REDEMPTION AND STOCKHOLDERS’ DEFICIT
FOR THREE MONTHS ENDED MARCH 31, 2022 AND FOR THE PERIOD FROM JANUARY 15, 2021
(INCEPTION) THROUGH MARCH 31, 2021
(Unaudited)
(As Restated)
Net loss
  $(3,334,058) 
Adjustments to reconcile net loss to net cash used in operating activities:
     
Financing expenses on derivative classified instrument
   12,137,500 
Change in fair value of derivative liabilities
   (9,000,000) 
Changes in operating assets and liabilities:
     
Prepaid expenses and other assets
   (1,278,834) 
Accounts payable and accrued expenses
   706,912 
   
 
 
 
Net cash used in operating activities
   (768,480) 
   
 
 
 
Cash Flows from Investing Activities:
     
Investment of cash into Trust Account
   (345,000,000) 
   
 
 
 
Net cash used in investing activities
   (345,000,000) 
   
 
 
 
Cash Flows from Financing Activities:
     
Proceeds from issuance of Class B and Class K common stock to Sponsor
   25,000 
Advances to related party
   (24,400) 
Proceeds from sale of Public Shares, net of transaction costs
   337,414,740 
Proceeds from sale of Private Placement Shares
   9,900,000 
   
 
 
 
Net cash provided by financing activities
   347,315,340 
   
 
 
 
Net increase in cash
   1,546,860 
Cash - beginning of period
   0   
   
 
 
 
Cash - end of period
  $1,546,860 
   
 
 
 
Supplemental disclosure of noncash investing and financing activities:
     
Deferred underwriting fees payable
  $12,075,000 
   
 
 
 
   
Common Stock Subject to
Possible Redemption
                           
   
Class A
   
Class A
   
Class B
   
Additional
Paid-in

Capital
  
Accumulated
Deficit
  
Total
Stockholders
Deficit
 
   
Shares
   Amount   Shares   
Amount
   
Shares
   
Amount
   
 
  
 
  
 
 
Balance as of January 1, 2022 (audited)
   34,500,000   $345,017.029    990,000   $99    5,000,000   $500   $0—    $(15,451,798)  $(15,451,199) 
Accretion of Class A common stock to redemption value
   —      28,158    —      —      —      —      —     (28,158)   (28,158) 
Net loss
   —      —      —      —      —      —      —     (243,037)   (243,037) 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
  
 
 
  
 
 
 
Balance as of March 31, 2022 (unaudited)
  
 
34,500,000
 
  
$
345,045,187
 
  
 
990,000
 
  
$
99
 
  
 
5,000,000
 
  
$
500
 
  
$
0  
 
 
$
(15,722,993
) 
 
$
(15,722,394
) 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
  
 
 
  
 
 
 
   
        
                           
   
    
                           
   
Common Stock Subject to
Possible Redemption
                           
   
Class A
   
Class A
   
Class B
   
Additional
Paid-in

Capital
  
Accumulated
Deficit
  
Total
Stockholders
Deficit
 
   
Shares
   
Amount
   
Shares
   
Amount
   
Shares
   
Amount
   
 
  
 
  
 
 
Balance as of January 15, 2021 (inception)
   0     $0—      0—     $0—      0—     
$

0—     $0—    $0—    $0—   
Issuance of common stock to Sponsor
   —      —      —      —      5,000,000    500    12,000   —     12,500 
Sale of Public Shares, net of $19,660,260 issuance costs
   34,500,000    325,339,740    —      —      —      —      —     —     —   
Sale of Private Placement Shares
   —      —      990,000    99    —      —      9,899,901   —     9,900,000 
Accretion of Class A Common Stock to redemption value
   —      19,660,260    —      —      —      —      (9,911,901)   (9,748,359)   (19,660,260) 
Net loss
   —      —      —      —      —      —      —     (3,334,058)   (3,334,058) 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
  
 
 
  
 
 
 
Balance as of March 31, 2021 (unaudited)
  
 
34,500,000
 
  
$
345,000,000
 
  
 
990,000
 
  
$
99
 
  
 
5,000,000
 
  
$
500
 
  
$
0  
 
 
$
(13,082,417
) 
 
$
(13,081,818
) 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
  
 
 
  
 
 
 
The accompanying notes are an integral part of these unaudited condensed financial statements.
 
45
Table of Contents
KHOSLA VENTURES ACQUISITION CO.
CONDENSED STATEMENTS OF CASH FLOWS
(Unaudited)
   
For The Three
Months Ended
March 31, 2022
  
For The Period From
January 15, 2021
(Inception) Through
March 31, 2021
 
Cash Flows from Operating Activities
         
Net loss
  $(243,037)  $(3,334,058) 
Adjustments to reconcile net loss to net cash used in operating activities:
         
Finance expense on fair value instruments
   —     12,137,500 
Gain on marketable securities (net), dividends and interest, held in Trust Account
   (28,158)   —   
Change in fair value of derivative liabilities
   (150,000)   (9,000,000) 
Changes in operating assets and liabilities:
         
Prepaid and other assets
   119,028   (1,278,834) 
Accounts payable and accrued expenses
   44,523   706,912 
   
 
 
  
 
 
 
Net cash used in operating activities
   (257,644)   (768,480) 
   
 
 
  
 
 
 
Cash Flows from Investing Activities
         
Investment
 of marketable securities held in Trust Account
   —     (345,000,000) 
   
 
 
  
 
 
 
Net cash used in investing activities
   —     (345,000,000) 
   
 
 
  
 
 
 
Cash Flows from Financing Activities
         
Proceeds from issuance of Class B and Class K common stock to Sponsor
   —     25,000 
Advances from (to) related party
   78,067   (24,400) 
Proceeds from sale of Public Share, net of transaction costs
   —     337,414,740 
Proceeds from sale of Private Placement Shares
   0     9,900,000 
   
 
 
  
 
 
 
Net cash provided by financing activities
   78,067   347,315,340 
   
 
 
  
 
 
 
Net (decrease) increase in cash
   (179,577)   1,546,860 
Cash - beginning of period
   0202,245   —   
   
 
 
  
 
 
 
Cash - end of period
  $22,668  $1,546,860 
   
 
 
  
 
 
 
Supplemental disclosure of noncash investing and financing activities:
         
Initial class A shares subject to possible redemption
  $—    $325,339,740 
Accretion of Class A shares to redemption value
  $28,158  $19,660,260 
Offering costs included in accrued expenses
  $—    $511,237 
Deferred underwriting fees payable
  $—    $12,075,000 
The accompanying notes are an integral part of these unaudited condensed financial statements.
6
KHOSLA VENTURES ACQUISITION CO.
NOTES TO FINANCIAL STATEMENTS
MARCH 31, 2021
(Unaudited)TO FINANCIAL STATEMENTS
Note 1 — 1—Description of
Organization, Business Operations and Going Concern (As Restated)
Khosla Ventures Acquisition Co. (the “Company”) is a blank check company formed as a Delaware corporation on January 15, 2021. The Company was incorporated for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses that the Company has not yet identified (the “Business(“Business Combination”).
As of March 31, 2021,2022, the Company had not commenced any operations. All activity for the period from January 15, 2021 (inception) through March 31, 20212022 relates to the Company’s formation, and Initial Public Offeringits initial public offering (the “IPO”), and the Company’s search for a target to consummate a Business Combination, which are all described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates
non-operating
income in the form of interest income on cash and cash equivalents from the proceeds derived from its initial public offering. The Company has selected December 31 as its fiscal year end.
The Company’s sponsor is Khosla Ventures SPAC Sponsor LLC (the “Sponsor”). The Company’s ability to commence operations is contingent upon obtaining adequate financial resources. On March 8, 2021, the Company consummated its initial public offering (the “IPO”)IPO of 30,000,000 shares of Class A common stock of the Company, par value $0.0001 per share (each, a “Public Share”), excluding additional Public Shares sold pursuant to the full exercise of the underwriters’ option to purchase additional Public Shares to cover over-allotments. The Public Shares were sold at a price of $10.00 per Public Share, generating gross proceeds to the Company of $300,000,000. On March 8, 2021, the Company’s underwriters exercised in full their option to purchase additional Public Shares in connection with the IPO. The underwriters exercised their option to purchase an additional 4,500,000 Public Shares from the Company at a price of $10.00 per share less the underwriting discount.fees payable. In total, the Company sold 34,500,000 Public Shares in connection with its IPO.IPO for gross proceeds of $345,000,000. The Underwritersunderwriters designate March 8, 2021 as the settlement date for such additional Public Shares pursuant to the Underwriting Agreement. The Public Shares were sold at a price of $10.00 per Public Share, generating gross proceeds to the Company of $345,000.000.
Simultaneously
with the closing of the IPO, the Company completed the private sale of 990,000 shares of Class A common stock of the Company, par value $0.0001 per share (the “Private Placement Shares”) at a purchase price of $10.00 per Private Placement Shares, to the Sponsor, generating aggregate gross proceeds to the Company of $9,900,000.
Following the closing of the IPO on March 8, 2021, and the full exercise of the underwriters’ overallotment option on March 8, 2021, an amount of $345,000,000 ($1010.00 per Public Share) of the proceeds from the IPO, including $12,075,000 of the underwriters’ deferred discountunderwriting fees payable was placed in a U.S. basedU.S.-based Trust Account at Goldman Sachs, maintained by Continental Stock Transfer & Trust Company, LLC, acting as trustee (“Trust Account”)., and invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 180 days or less or in money market funds meeting certain conditions under
Rule 2a-7
promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds in the Trust Account that may be released to the Company to pay its franchise and income taxes and expenses relating to the administration of the Trust Account, the proceeds from the IPO, including proceeds from the sale of Private Placement Shares and forward purchase shares, which are held in the Trust Account will not be released until the earliest of (a) the completion of the Company’s initial business combination,Business Combination, (b) the redemption of any public shares properly tendered in connection with a stockholder vote to amend the Company’s Amended and Restated Certificate of Incorporation (i) to modify the substance or timing of its obligation to redeem 100% of its public shares if the Company does not complete its initial business combinationBusiness Combination within 24 months from the closing of the IPO or (ii) with respect to any other provisions relating to stockholders’ rights
or pre-initial business combination
Business Combination activity, and (c) the redemption of all of the Company’s public shares if it is unable to complete its business combinationBusiness Combination within 24 months from the closing of the IPO, subject to applicable law.
On June 9, 2021, the Company entered into an agreement for a proposed initial Business Combination with Valo Health, a technology company using human-centric data and artificial intelligence (AI) powered computation to transform the drug discovery and development process. Concurrently with such an agreement, the Company also entered into subscription agreements (the “PIPE I Subscription Agreements”) with certain investors (collectively, the “PIPE I Investors”), pursuant to, and on the terms and subject to the conditions of which, the PIPE I Investors collectively subscribed for 16,855,000 shares of Class A common stock for an aggregate purchase price equal to $168,550,000 (the “PIPE I Investment”). On July 30, 2021, the Company entered into additional subscription agreements (the “PIPE II Subscription Agreements”) with certain investors (collectively, the “PIPE II Investors”), pursuant to, and on the terms and subject to the conditions of which, the PIPE II Investors collectively subscribed for an additional 3,231,250 shares of KVSA Common Stock for an aggregate purchase price equal to $32,312,500 (the “PIPE II Investment”). However, on November 15, 2021, the Company and Valo Health mutually agreed to terminate the proposed initial Business Combination based on market conditions, particularly in the biotechnology area. The PIPE I Investment and PIPE II Investment were also both terminated upon the termination of the proposed initial Business Combination with Valo Health.
7
The Company’s management has broad discretion with respect to the specific application of the net proceeds of its IPO and the sale of Private Placement Shares, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets that together have an aggregate fair market value equal to at least 80% of the net assets held in the Trust Account (excluding the deferred underwriting commissionsfees payable and taxes payable on the interest earned on the Trust Account) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise is not required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination. Upon the closing of the IPO, management has agreed that an amount equal to at least $10.00 per Public Share sold in the IPO, including the proceeds from the sale of the private placement shares and the sale of forward purchase shares, will be held in a Trust Account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 180 days or less or in money market funds meeting certain conditions under
Rule 2a-7
promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations.
The Company will provide its holders of the Public Shares (the “Public Stockholders”) of the Company’s issued and outstanding Class A common stock, par value $0.0001 per share, sold in the IPO (the “Public Shares”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The
per-share
amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissionsfees payable the Company will pay to the underwriters (as discussed
5
Table of Contents
in Note 6).underwriters. These Public Shares were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering,IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to the amended and restated certificate of incorporation, which was adopted by the Company upon the consummation of the Initial Public OfferingIPO (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a stockholder approval of the transactions is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the transaction. If the Company seeks stockholder approval in connection with a Business Combination, the holders of the Founder Shares (as defined below) prior to this Initial Public OfferingIPO (the “Initial Stockholders”) have agreed to vote their Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public OfferingIPO in favor of a Business Combination. In addition, the Initial Stockholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination.
Notwithstanding the foregoing, the Company’s Amended and Restated Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Class A common stock sold in the Initial Public Offering,Shares, without the prior consent of the Company.
8
The holders of the Founder Shares (the “initial stockholders”“Initial Stockholders”) have agreed not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation A)(A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or B)(B) with respect to any other provision relating to stockholders’ right rights
or pre-initial
Business Combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.
If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public OfferingIPO (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes, if any (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.
The Initial StockholdersStockholders’ have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Stockholders should acquire Public Shares in or after the Initial Public Offering,IPO, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commissionfees payable held in the Trust Account in the event the Company does not complete a Business Combination within in the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combinationBusiness Combination agreement, reduce the amount of funds in the Trust Account to
6
Table of Contents
below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public OfferingIPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
LiquidityGoing Concern and Capital ResourcesLiquidity
As of March 31, 2021,2022, the Company had $1,546,860$22,668 in its operating bank account, $345,000,000$657,731 in cashprepaid expenses, and $345,045,187 in securities held in the Trust Account to be used for a Business Combination or to repurchase or redeem its common stock in connection therewith and working capital deficit of $1,530,142.$3,647,394. For the three months ended March 31, 2022, $28,158 of the amount on deposit in the Trust Account represented interest income, which is available for payment of franchise taxes and expenses in connection with the liquidation of the Trust Account. For the period from January 15, 2021 (inception) to March 31, 2021, $0 of the amount on the deposit in the Trust Account represented interest income
. In addition, the Working Capital Loan and advances from related parties are available to the Company to fund operations. Please see Note 4 for additional information. 
9
If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, suspending the pursuit of a Business Combination. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.
As a result of the above, in connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update
(“ASU”)
2014-15, “Disclosures
“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the liquidity condition and date for mandatory liquidation and dissolutionconditions raise substantial doubt about the Company’s ability to continue as a going concern through approximately one year from the date these condensed financial statements were issued.of filing. These condensed financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.
Prior to the consummation of the IPO, the Company’s liquidity needs have been satisfied through receipt of a $25,000 capital contribution from the Sponsor in exchange for the issuance of the Founder Shares to the Sponsor, and a $300,000 promissory note payable to the Sponsor. Subsequent to the consummation of the Initial Public Offering, the Company received the net proceeds not held in the Trust Account of $3,000,000.
In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into shares of the post-transaction company at $10.00 per share at the option of the lender. As of March 31, 2021, the Company has 0borrowings under the Working Capital Loans.
Risks and Uncertainties
Management continues to evaluate the impact of
the
COVID-19
pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Note 2 — RestatementThe credit and Revision of Previously Issued Financial Statements
Subsequent to filing of its Form
10-Q,
the Company identified errors in its historical financial statements relatedmarkets have experienced extreme volatility and disruptions due to the accounting for the Class A common stockcurrent conflict between Ukraine and the Class K Founder Shares. Because the Class A common stock issued in the Initial Public Offering can be redeemed or become redeemable subjectRussia. The conflict is expected to have further global economic consequences, including but not limited to the occurrencepossibility of future events considered outsideseverely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in inflation rates and uncertainty about economic and political stability. In addition, the United States and other countries have imposed sanctions on Russia which increases the risk that Russia, as a retaliatory action, may launch cyberattacks against the United States, its government, infrastructure and businesses. Any of the Company’s control, the Company should have classified all of these redeemable shares in temporary equity and remeasured these redeemable shares to their redemption value (i.e., $10.00 per share) as of the end of the first reporting period after the date of the Company’s Initial Public Offering. The Company also concluded that it incorrectly accounted for the Class K Founder Shares as permanent equity versus a derivative liability and incorrectly accounted for certain items on the cash flow statement.
7
Table of Contents
The tables below
summarize the effects of the restatement on the condensed balance sheet as of March 31, 2021, and on the condensed statementsforegoing consequences, including those we cannot yet predict, may cause our business, financial condition, results of operations and cash flows for the period from January 15, 2021 (inception) through March 31, 2021.
price of our ordinary shares to be adversely affected.
   
As of March 31, 2021
 
   
As Previously
Reported
  
Restatement
Adjustment
  
As Restated
 
Balance Sheet
             
Total assets
  $347,850,694  $0    $347,850,694 
   
 
 
  
 
 
  
 
 
 
Liabilities, common stock subject to possible redemption, and stockholders’ deficit
             
Total current liabilities
  $706,912  $600  $707,512 
Deferred underwriting fees payable
   12,075,000   0     12,075,000 
Class K Founder Shares derivative liabilities
   0     3,150,000   3,150,000 
   
 
 
  
 
 
  
 
 
 
Total liabilities
   12,781,912   3,150,600   15,932,512 
Class A common stock subject to possible redemption, 34,500,000 shares at $10.00
   330,068,780   14,931,220   345,000,000 
Stockholders’ deficit
             
Preferred stock - $0.0001 par value
   0     0     0   
Class A common stock - $0.0001 par value
   149   (50)   99 
Class B common stock - $0.0001 par value
   500   0     500 
Class K common stock - $0.0001 par value
   500   (500)   0   
Additional
paid-in-capital
   5,195,411   (5,195,411)   0   
Accumulated deficit
   (196,558)   (12,885,859)   (13,082,417) 
   
 
 
  
 
 
  
 
 
 
Total stockholders’ equity (deficit)
   5,000,002   (18,081,820)   (13,081,818) 
   
 
 
  
 
 
  
 
 
 
Total liabilities, common stock subject to possible redemption, and stockholders’ equity (deficit)
  $347,850,694  $0    $347,850,694 
   
 
 
  
 
 
  
 
 
 
   
Period From January 15 (Inception) Through March 31, 2021
 
   
As Previously
Reported
  
Restatement
Adjustment
  
As Restated
 
Statement of Operations
             
Loss from operations
  $(196,558)  $0    $(196,558) 
Financing expenses on derivative classified instrument
   0     (12,137,500)   (12,137,500) 
Change in fair value of derivative liabilities
   0     9,000,000   9,000,000 
Net loss
  $(196,558)  $(3,137,500)  $(3,334,058) 
Weighted average shares outstanding of Class A common stock subject to possible redemption
   33,034,898   (21,994,898)   11,040,000 
Basic and diluted net loss per common stock, Class A
  $0.00  $(0.20)  $(0.20) 
Weighted average shares outstanding of Class A
non-redeemable
common stock
   0     316,800   316,800 
Basic and diluted net loss per common stock, Class A
  $0    $(0.20)  $(0.20) 
Weighted average shares outstanding of Class B
non-redeemable
common stock
   5,463,372   (463,372)   5,000,000 
Basic and diluted net loss per common stock, Class B
  $(0.04)  $(0.16)  $(0.20) 
   
Period From January 15 (Inception) Through March 31, 2021
 
   
As Previously
Reported
  
Restatement
Adjustment
  
As Restated
 
Statement of Cash Flows
             
Net loss
  $(196,558)  $(3,137,500)  $(3,334,058) 
Financing expenses on derivative classified instrument
   0     12,137,500   12,137,500 
Change in fair value of derivative liabilities
   0     (9,000,000)   (9,000,000) 
Changes in operating assets and liabilities
             
Accounts payable and accrued expenses
   147,442   559,470   706,912 
Net cash used in operating activities
   (1,327,950)   559,470   (768,480) 
Cash flow from financing activities
             
Proceeds from issuance of Class B and Class K common stock to sponsor
   25,600   (600)   25,000 
Proceeds from sale of Public Shares, net of transaction costs
   338,250,790   (836,050)   337,414,740 
Advances to related party
   (25,000)   600   (24,400) 
Net cash provided by financing activities
   347,874,810   (559,470)   347,315,340 
   
 
 
  
 
 
  
 
 
 
Net change in cash
  $1,546,860  $0    $1,546,860 
   
 
 
  
 
 
  
 
 
 
8
Table of Contents
Note 3 — 2—Summary of Significant Accounting Policies (As Restated)
Basis of Presentation
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form
10-Q
and Article 8 of Regulation
S-X
of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial statements, operating results and cash flows for the periodsperiod presented.
The interim results for the period ended March 31, 20212022 are not necessarily indicative of the results to be expected for the year ending December 31, 20212022 or for any future periods.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply
to
non-emerging
growth companies but any such an election to opt out is irrevocable.
10
The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $1,546,860 in0 cash and 0cash equivalents as of March 31, 2022 and December 31, 2021.
CashMarketable Securities Held in Trust Account
AsThe Company’s portfolio of March 31, 2021, the Company had $345,000,000 in
cashinvestments held in Goldman Sachs funds.
the Trust Account are comprised solely of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less, classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in gain on marketable securities, dividends and interest held in the Trust Account in the accompanying statements of operations. The fair value for trading securities is determined using quoted market prices in active markets.
Common Stock Subject to Possible Redemption (As Restated)
The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in ASC Topic 480.
Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock is classified as stockholders’ equity.
The Company’s Class A common stock feature contains certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption are classified as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet.sheets. Accordingly, as of March 31, 2022 and December 31, 2021, 34,500,000 shares of Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet.sheets.
9
Table of Contents
The Class A common stock subject to possible redemption are subject to the subsequent measurement guidance in ASC
Topic 480-10-S99.
Under such guidance, the Company must subsequently measure the shares to their redemption amount because, as a result of the allocation of net proceeds to transaction costs, the initial carrying amount of the common stock is less than $10.00 per share. In accordance with the guidance, the Company has elected to measure the common stock subject to possible redemption to their redemption amount (i.e., $10.00 per share) immediately as if the end of the first reporting period after the Initial Public Offering,IPO, March
8,
, 2021, was the redemption date. Such changes are reflected in
additional paid-in
capital, or in the absence of
additional paid-in
capital, in accumulated deficit. FromFor the three months ended March 31, 2022, the Company recorded an accretion of $28,158, of which $28,158 was recorded in accumulated deficit. For the period from January 15, 2021 (inception) through March 31, 2021, the Company recorded an accretion of $19,660,260, of which $9,911,901 was recorded in additional
paid-in
capital and $9,748,359 was recorded in accumulated deficit.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000.coverage. As of March 31, 2022 and December 31, 2021, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Financial
Instruments11
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.
Derivative Financial Instruments
The Company accounts for derivative financial instruments in accordance with ASC Topic 815, “Derivatives and Hedging”.Hedging.” For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value upon issuance and remeasured at each reporting date, with changes in the fair value reported in the statementstatements of operations. The classification of derivative financial instruments is evaluated at the end of each reporting period.
Fair Value Measurements
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the ASC Topic 820 approximates the carrying amounts represented in the balance sheet.sheets.
The fair value hierarchy is categorized into three levels based on the inputs as follows:
Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level 2: Observable inputs other than Level 1 inputs. Example of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
The fair value of the Company’s financial assets and liabilities, approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities during the reporting period. Actual results could differ from those estimates.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
10
Table of Contents
Offering Costs
Offering costs consist of legal, accounting, and other costs incurred through the balance sheet date that are directly related to the Initial Public OfferingIPO and were charged to temporary equity upon the completion of the IPO. Offering costs were $19,660,260 for the period from January 15, 2021 (inception) through March 31,
2021
.
Income Taxes
The Company complies with the accounting and reporting requirements of ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As of March 31, 2021, the deferred tax asset is de minimis.
ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must
be more-likely-than-not
to be sustained upon examination by taxing authorities. The Company’s management determined that the United States is the Company’s only major tax jurisdiction.
12
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
11
Table of Contents
Net LossIncome (Loss) Per Share of Common Stock (As Restated)
Net lossincome (loss) per share is computed by dividing net lossincome (loss) by the weighted average number of common stock outstanding during the period, excluding common stock shares subject to forfeiture.
Class K Founder Sharescommon stock will convert into Class A common stock after the initial Business Combination only to the extent certain triggering events occur prior to the 10th anniversary of the initial Business Combination, including three equal triggering events based on the Company’s stock trading at $30.00, $40.00 and $50.00 per share following the first anniversary of the closing of the initial Business Combination and also upon specified strategic transactions. The Company has not considered the effect of the Class K Founder Sharescommon stock in the calculation of diluted lossincome (loss) per share since the conversion of Class K Founder Sharescommon stock into Class A common stock is contingent upon the occurrence of future events.
Class B Founder Shares and Private Placement Shares are included in the calculation
of non-redeemable earnings
loss per share.
The Company’s statementstatements of operations includesinclude a presentation of income (loss)loss per share for shares of common stock subject to possible redemption in a manner similar to the
two-class
method of income (loss)loss per share. With respect to the accretion of the Class A common stock subject to possible redemption and consistent with ASC
Topic 480-10-S99-3A,
the Company has treated the accretion in excess of fair value in the same manner as a dividend, to the extent the redemption value exceeds the fair value, in the calculation of the net income/(loss) per common stock. As of March 31, 2022 and December 31, 2021, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted lossincome (loss) per share is the same as basic loss per share for the periodperiods presented.
A reconciliation of net loss per common stock is as follows:
 
Inception-to-Date,
March 31, 2021
  
Class A subject
to possible
redemption
   
Class A
   
Class B
 
Allocation of undistributable losses
  $(2,250,318)   $(64,574)   $(1,019,166) 
   
 
 
   
 
 
   
 
 
 
Net income/(loss) to common stock
  $(2,250,318)   $(64,574)   $(1,019,166) 
   
 
 
   
 
 
   
 
 
 
Weighted average shares outstanding, basic and diluted
   11,040,000    316,800    5,000,000 
   
 
 
   
 
 
   
 
 
 
Basic and diluted net loss per share
  $(0.20)   $(0.20)   $(0.20) 
   
 
 
   
 
 
   
 
 
 
  
For The Three Months Ended

March 31, 2022
  
For The Period From January 15,
2021 (Inception) Through
March 31, 2021
 
Net loss

 $(243,037)  $(3,334,058) 
Accretion of temporary equity in excess of fair value
  (28,158)   0— 
Net loss including accretion of temporary equity in excess of fair value
 $(271,195)  $(3,334,058) 
  
 
 
  
 
 
 
   
For The Three Months Ended March 31, 2022
 
   
Class A-t (Temporary)
   
Class A-p (Permanent)
   
Class B
 
Basic and diluted net loss per share
               
Numerator
               
Allocation of net loss including accretion of temporary equity in excess of fair value
  $(231,075)  $(6,631)  $(33,489)
Deemed dividend for accretion of temporary equity in excess of fair value
   28,158    0    0 
   
 
 
   
 
 
   
 
 
 
Allocation of net loss and deemed dividend
  $(202,917)   $(6,631)   $(33,489) 
   
 
 
   
 
 
   
 
 
 
Denominator
               
Weighted average shares outstanding, basic and diluted
   34,500,000    990,000    5,000,000 
Basic and diluted net loss per share
  $(0.01)   $(0.01)   $(0.01) 
13
   
For The Period from January 15, 2021 (Inception) Through March 31, 2021
 
   
Class A-t (Temporary)
   
Class A-p (Permanent)
   
Class B
 
Basic and diluted net loss per share
               
Numerator
               
Allocation of net loss including accretion of temporary equity in excess of fair value
  $(2,809,063)  $(80,608)  $(444,387)
Deemed dividend for accretion of temporary equity in excess of fair value
   0      0      0   
   
 
 
   
 
 
   
 
 
 
Allocation of net loss and deemed dividend
  $(2,809,063)  $(80,608)  $(444,387)
   
 
 
   
 
 
   
 
 
 
Denominator
               
Weighted average shares outstanding, basic and diluted
   11,040,000    316,800    5,000,000 
Basic and diluted net loss per share
  $(0.25)  $(0.25)  $(0.09)
Recent Accounting Pronouncements
Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the accompanying financial statements.
Note 4 — 3—Initial Public Offering
Pursuant to the IPO, the Company sold 34,500,000 Public Shares at a purchase price of $10.00 per Public Share, including 4,500,000 Public Shares sold pursuant to the full exercise of the underwriters’ option to purchase additional Public Shares to cover over-allotments.
12
Table of Contents
Simultaneously with the closing of the IPO, the Company completed the private sale of 990,000 shares of Class A common stock of the Company, par value $0.0001 per share (the “Private Placement Shares”) at a purchase price of $10.00 per Private Placement Shares, to
the
Company’s sponsor, Khosla Ventures SPAC Sponsor LLC, generating aggregate gross proceeds to the Company of $9,900,000.
Note 5 — 4—Related Party
Transactions
Advances FromPromissory Note – Related Party (As Restated)
On February 8,January 19, 2021, the Company issued a promissory note (the “Promissory Note”) to the Sponsor and an affiliate of the Sponsor, pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The Promissory Note
was
non-interest
bearing and payable on the earlier of (i) December 31, 2021 and (ii) the completion of the Initial Public Offering.IPO. The outstanding balance under the promissory note was repaid upon consummation of the IPO. The Company can no longer borrow under the Promissory Note asNote.
Due to Related Party
An affiliate of the Sponsor paid certain operating costs on behalf of the Company. These advances are due on demand and
non-interest
bearing. During the three months ended March 31, 2022 and the period from January 15, 2021 (inception) through March 31, 2021, the related party paid $78,067 and $600 of operating costs on behalf of the Company, respectively. As of March 31, 2022 and December 31, 2021, the amount due to the related party was $600.$78,667 and $600, respectively.
Founder Shares
On January 19, 2021, the Sponsor acquired 10,000,000 Founder Shares (the “Founder Shares”) for an aggregate purchase price of $25,000, consisting of 5,000,000 Class B Founder Shares (also known as “Class B common stock”) and 5,000,000 Class K Founder Shares (also known as “Class K common stock”). Prior to the initial investment in the Company of $25,000 by the Sponsor, the Company had no assets, tangible or intangible. The per share purchase price of the Founder Shares was determined by dividing the amount of cash contributed to the companyCompany by the aggregate number of Founder Shares issued. On
February
28,
, 2021, the Sponsor entered into a security assignment agreement with
six
of the Company’s independent directors and assigned 240,000 shares of Class B
Found
er
S
har
e
s
Founder Shares at an aggregate price of $600.
14
Class B Founder Shares
The Class B Founder Shares will automatically convert into shares of Class A common stock on the first business day following the completion of our initial business combination,Business Combination, at a ratio such that the number of shares of Class A common stock issuable upon conversion of all Class B Founder Shares will equal, in the aggregate on
an
as-converted
basis, 15% of the sum of (i) the total number of all shares of Class A common stock issued and outstanding upon completion of this offering (including any over-allotment shares if the underwriters exercise their overallotment option), plus (ii) the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion of the Class B Founder Shares plus (iii) unless waived, the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities (as defined herein) or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial business combination,Business Combination, excluding (x) any shares of Class A common stock or equity-linked securities exercisable for or convertible into shares of Class A common stock issued, deemed issued, or to be issued, to any seller in the initial business combination,Business Combination, (y) any shares of Class A common stock issuable upon conversion of the Class K Founder Shares and (z) any Private Placement Shares. Prior to our initial business combination,Business Combination, only holders of shares of our Class B common stock will be entitled to vote on the appointment of directors.
13
Table of Contents
Class K Founder Shares (As Restated)
The Class K Founder Shares will convert into shares of Class A common stock after the initial business combinationBusiness Combination only to the extent certain triggering events occur prior to the 10th anniversary of the initial business combination,Business Combination, including three equal triggering events based on our stock trading at $30.00, $40.00 and $50.00 per share following the first anniversary of the closing of our initial business combinationBusiness Combination and also upon specified strategic transactions, in each case, as described in this prospectus. The Class K Founder Shares will be convertible into shares of Class A common stock at a ratio such that the number of shares of Class A common stock issuable upon conversion of all founder sharesFounder Shares (including both Class B founder sharesFounder Shares and Class K Founder Shares) will equal, in the aggregate on an
an as-converted
basis,
30% of the sum of (i) the total number of all shares of Class A common stock issued and outstanding upon completion of this offering (including any over-allotment shares if the underwriters exercise their overallotment option), plus (ii) the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion of the Class B Founder Shares and Class K Founder Shares plus (iii) unless waived, the total number of shares of Class A common stock issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities (as defined herein) or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial business combination,Business Combination, excluding (x) any shares of Class A common stock or equity-linked securities exercisable for or convertible into shares of Class A common stock issued, deemed issued, or to be issued, to any seller in the initial business combinationBusiness Combination and (y) any Private Placement Shares. Prior to our initial business combination,Business Combination, only holders of shares of our Class B Founder Sharescommon stock were entitled to vote on the appointment of directors.
The Company’s previously issued Amended Filing of Form
10-Q
classifiedCompany accounts for the Class K common stockFounder Shares as a componentequity linked instruments. Based on the guidance in ASC Topic 815, certain adjustments to the settlement amount of stockholders’ equity. Upon reassessment, the Company determined that there was an error in the accounting treatment as Class K commonFounder Shares are based on a variable that is not an input to the fair value of a
“fixed-for-fixed”
option as defined under ASC
Topic 815-40.
The Class K Founder Shares are recorded as liabilities as these shares are not considered indexed to the Company’s own stock has features that preclude itand not eligible for an exception from such classification. The correction of this error is reflected in Note 2 to these unaudited condensed financial statements.
derivative accounting.
Working Capital Loans
In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. To date, the Company had no borrowings under the Working Capital Loans.
15
Private Placement Shares
Simultaneously with the closing of the IPO, the Sponsor has purchased 990,000 Class A common stock at a price of $10.00 per stockshare in a private placement for an aggregate purchase price of $9,900,000. The Private Placement Shares are identical to the shares of Class A common stock shares sold in this offering, subject to certain limited exceptions.
The Private Placement Shares holders do not have the option to redeem their Class A common stock and as a result, the proceeds received in connection with the Initial Public OfferingIPO are excluded from temporary equity. The par value of these shares and related additional paid in capital are classified as permanent equity in the Company’s financial statements.
The initial stockholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Shares until 30 days after the completion of the initial business combination.Business Combination.
14
Table of Contents
Forward Purchase Agreement
The Company has entered into a forward-purchase agreement pursuant to which the Sponsor agreed to purchase an aggregate of up to 2,500,000 shares of our Class A common stock (the “forward-purchase shares”) for $10.00 per share, or an aggregate maximum amount of $25,000,000, in a private placement that would close simultaneously with the closing of the initial business combination.Business Combination. The proceeds from the sale of these forward-purchase shares, together with the amounts available to the Company from the Trust Account (after giving effect to any redemptions of public shares) and any other equity or debt financing obtained by the Company in connection with the business combination,Business Combination, will be used to satisfy the cash requirements of the business combination,Business Combination, including funding the purchase price and paying expenses and retaining specified amounts to be used by the post-business combinationpost-Business Combination company for working capital or other purposes. To the extent that the amounts available from the Trust Account and other financing are sufficient for such cash requirements, the Khosla Entitiessponsor (together with any permitted transferees under the forward-purchase agreement) may purchase less than 2,500,000 forward-purchase shares. The forward-purchase shares would be identical to the public shares being sold in this offering, except the forward-purchase shares would be subject to transfer restrictions and certain registration rights, as described herein. The Company performed an assessment in accordance with ASC Topic 480 and ASC Topic 815, to conclude whether the forward-purchase shares constitute a liability and a derivative such that it will be fair valued separately from the Company’s common stock. The Company concludes that the forward-purchase shares should be equity-classified and its embedded features should not be bifurcated.
Note 6 — 5—Commitments & Contingencies
Registration Rights
The holders of the Founder Shares and Private Placement Shares are entitled to registration rights pursuant to the registration agreement signed prior to the consummation of the Initial Public Offering.IPO. The holders are entitled to certain demand and “piggyback” registration rights. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statements to become effective until termination of the
applicable
lock-up
period.
Underwriting Agreement
The Company granted the underwriters an option to cover over-allotments and for market stabilization purposes. The over-allotment option entitled the underwriters to purchase on a pro rata basis up to 4,500,000 additional Public Shares at the Initial Public OfferingIPO price, less the underwriting discounts and commissions.fees payable. On March 8, 2021, the Company’s underwriters exercised in full their option to purchase additional Public Shares in connection with the IPO. The underwriters exercised their option to purchase 4,500,000 Public Shares from the Company at a price of $10.00 per share less the underwriting discount.fees payable. This transaction settled on March 8, 2021.
Note 7 — 6—Stockholders’ Equity (Deficit) (As Restated)
Deficit
Preferred Stock
— - The Company is authorized to issue 1,000,000 shares of preferred stock
with a
par value
of
$0.0001 $0.0001 per share. As of March 31, 2022 and December 31, 2021, there were 0 shares of preferred stock issued or outstanding.
16
Class
Class A Common Stock
— - The Company is authorized to issue 200,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of the Company’s Class A common stock are entitled to one vote for each share. As of March 31, 2022 and December 31, 2021, there were 990,000 shares of Class A common stock issued andor outstanding, excluding 34,500,000 shares of common stock subject to possible redemption.
Class
 B Common Stock
— - The Company is authorized to issue 30,000,000 shares of Class B common stock with a par value of $0.0001 per share. As of March 31, 2022 and December 31, 2021 there were 5,000,000 shares of Class B common stock were issued and outstanding.
Common stockholders of record are entitled to one vote for each share held on all matters to be voted on by stockholders. Except as described below, holdersHolders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of the stockholders except as required by law.
15
Table of Contents
Note 8 — 7—Fair Value
Measurements
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of March 31, 2022 including the fair value hierarchy of the valuation inputs that the Company utilized to determine such fair value.
   
Level 1
   
Level 2
   
Level 3
   
Total
 
Assets
                    
Marketable securities held in Trust Account
  $345,045,187   $—     $—     $345,045,187 
Liabilities:
                    
Class K Founder Shares derivative liabilities
   —      —      0  —    0  — 
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2021 including the fair value hierarchy of the valuation inputs that the Company utilized to determine such fair value.
 
Description
  
Level
   
March 31, 2021
 
Assets:
          
Marketable securities held in Trust Account
   1   $345,000,000 
Liabilities:
          
Derivative liability – Class K Founder Shares
   3   $3,150,000 
   
Level 1
   
Level 2
   
Level 3
   
Total
 
Assets
                    
Marketable securities held in Trust Account
  $345,017,029   $—     $—     $345,017,029 
Liabilities:
                    
Derivative liability - Class K Founder Shares
   —      —      150,000    150,000 
Class K Founder Shares LiabilityDerivative Liabilities
Class K common stockFounder Shares is accounted for as a liability in accordance with ASC Topic 815 and presented as a derivative liability on the accompanying March 31, 2022 and December 31, 2021 balance sheet.sheets. The derivative liability was measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of derivative liability in the statementstatements of operations. In order to capture the market conditions associated with the Class K Founder Shares liability,derivative liabilities, the Company applied an approach that incorporated a Monte Carlo simulation, which involved random iterations of future stock-price paths over the contractual life of the Class K Founder Shares. Based on assumptions regarding potential changes in control of the Company, and the probability distribution of outcomes, the payoff to the holder was determined based on the achievement of the various market thresholds within each simulated path. The present value of the payoff in each simulated trial is calculated, and the fair value of the liability is determined by taking the average of all present values.
The key inputs into the Monte-Carlo simulation model for the Class K Founder Shares derivative liabilities were as follows on the date of issuance and as of March 31, 2022 and December 31, 2021:
 
Input
  
January 22, 2021

inception
 
March 31, 2021
   
March 31, 2022
 
December 31, 2021
 
Risk-free interest rate
   1.14%   1.77%    2.34%   1.54% 
Term to business combination
   0.8 years   0.6 years 
Term to Business Combination
   0.7 years   0.5 years 
Expected volatility
   22.5%   15.5%    4.50%   10.50% 
Stock Price
  $10.00  $10.10 
Stock price
  $9.78  $9.70 
Dividend yield
   0.0%   0.0%    0.00%   0.00% 
17
The following table presents a summary of the changes in the fair value of the Class K Founder Shares liability,derivative liabilities, a Level 3 liability, measured on a recurring basis, as offor the period from January 1, 2022 through March 31, 2021:2022:
 
   
Class K

Founder Shares

Derivative Liability
 
Fair value, January 22, 2021
  $ 12,150,000 
Change in fair value of Class K Founder Shares liability
   (9,000,000) 
   
 
 
 
Fair value, March 31, 2021
  
$
3,150,000
 
   
 
 
 
   
Class K Founder
Shares
Derivative
Liabilities
 
Fair value at January 1, 2022
  $150,000 
Change in fair value
   (150,000) 
   
 
 
 
Fair value as of March 31, 2022
  $0—   
   
 
 
 
There were 0 transfers to and from Levels 1, 2, and 3 duringfor the periodthree months ended March 31, 2022.
The following table presents a summary of the changes in the fair value of the Class K Founder Shares derivative liabilities, a Level 3 liability, measured on a recurring basis, for the period from January
15
, 2021
(inception)
through March 31, 2021:
   
Class K Founder
Shares
Derivative
Liabilities
 
Fair value at January 
15
, 2021 (Inception)
  $ 12,150,000 
Change in fair value
   (9,000,000) 
  
 
 
 
Fair value as of March 31, 2021
  $3,150,000 
  
 
 
 
There were 0 transfers to and from Levels 1, 2, and 3 for the period from January
15, 2021 (inception)
to March 31, 2021.
Note 8—Income Taxes
The Company’s taxable income primarily consists of interest income on the Trust Account, less any franchise taxes. The Company’s formation costs are generally
considered start-up
costs and are not currently deductible.
We recorded an income tax provision of $0 and $0 for the three months ended March 31, 2022, and for the period from January 15, 2021 (inception) through March 31, 2021, respectively. The effective income tax rate for the three months ended March 31, 2022, and for the period from January 15, 2021 (inception) through March 31, 2021 was 0% and 0%, respectively. The 0% effective income tax rate differs from the federal statutory rate of 21% as a result of 
non-deductible
transaction costs, and the movement of the valuation allowance against our U.S. state and federal net deferred tax assets. As of March 31, 2022 and December 31, 2021, the Company had $204,813 and $182,971 of U.S. federal and state net operating loss carryovers available to offset future taxable income, respectively.
In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of deferred tax assets and therefore established a full valuation allowance. For the three months ended March 31, 2022, and for the period from January 15, 2021 (inception) to March 31, 2021, the valuation allowance was
 $1,247,809 and $41,277, respectively.
The Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various taxing authorities. There were 0 unrecognized tax benefits as of March 31, 2022 and December 31, 2021. NaN amounts were accrued for the payment of interest and penalties as of March 31, 2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

 
1618
Table of Contents
Note 9 — Subsequent EventsItem 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The
Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date the financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements, other than those disclosed below.
On June 9, 2021, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Valo Health, Inc., a Delaware corporation (“Valo”), Valo Health, LLC, a Delaware limited liability company (“Valo Holdco” and, together with Valo, the “Valo Parties”) and Killington Merger Sub Inc., a Delaware corporation and a direct wholly-owned subsidiary of the Company (“Merger Sub”).
On June 9, 2021, concurrently with the execution of the Merger Agreement, the Company also entered into subscription agreements (the “PIPE I Subscription Agreements”) with certain investors (collectively, the “PIPE I Investors”), pursuant to, and on the terms and subject to the conditions of which, the PIPE I Investors have collectively subscribed for 16,855,000 shares of Class A common stock, par value $0.0001 per share (“KVSA Common Stock”), for an aggregate purchase price equal to $168,550,000 (the “PIPE I Investment”).
On July 30, 2021, the Company entered into additional subscription agreements (the “PIPE II Subscription Agreements”) with certain investors (collectively, the “PIPE II Investors”), pursuant to, and on the terms and subject to the conditions of which, the PIPE II Investors have collectively subscribed for an additional 3,231,250 shares of KVSA Common Stock for an aggregate purchase price equal to $32,312,500 (the “PIPE II Investment”). The PIPE I Investment and PIPE II Investment are each expected to be consummated substantially concurrently with the Closing.
17
Table of Contents
ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Khosla Ventures Acquisition Co. References to our “management” or our “management team” refer to our officers and directors, references to the “Sponsor” refer to Khosla Ventures SPAC Sponsor LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form
10-Q
including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward- looking statements, please refer to the Risk Factors section of the Company’s final prospectus for its Initial Public Offeringinitial public offering (“IPO”) filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Restatement
This Management’s Discussion and Analysis of Financial Condition and Results of Operations has been amended and restated to give effect to the restatement of our unaudited financial statements as of and for the period ended March 31, 2021 (the “Restatement”).
Subsequent to filing of its Form 10-Q, the Company identified errors in its historical financial statements related to the accounting for the Class A common stock and the Class K Founder Shares. Because the Class A common stock issued in the Initial Public Offering can be redeemed or become redeemable subject to the occurrence of future events considered outside of the Company’s control, the Company should have classified all of these redeemable shares in temporary equity and remeasured these redeemable shares to their redemption value (i.e., $10.00 per share) as of the end of the first reporting period after the date of the Company’s Initial Public Offering. The Company also concluded that it incorrectly accounted for the Class K Founder Shares as permanent equity versus a derivative liability.
The Restatement is more fully described in Note 2 to the Notes to Financial Statements.
Overview
We are a blank check company formed under the laws of the State of Delaware on January 15, 2021 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar Business Combinationbusiness combination with one or more businesses. We intend to effectuate our Business Combinationinitial business combination using cash from the proceeds of the Initial Public OfferingIPO and the sale of the Private Placement Shares,private placement shares and forward purchaseforward-purchase shares, our capital stock, debt or a combination of cash, stock and debt. We are an emerging growth company and, as such, we are subject to all of the risks associated with emerging growth companies.
Our Sponsorsponsor is Khosla Ventures SPAC Sponsor LLC, a Delaware limited liability company. The registration statement for our Initial Public OfferingIPO was declared effective on March 3, 2021. On March 8, 2021, we consummated our Initial Public OfferingIPO of 34,500,000 Public Shares, including 4,500,000 Over-Allotment Shares at $10.00 per share, generating gross proceeds of $345,000,000, and incurring offering costs of $19,660,260, inclusive of $12,075,000 in deferred underwriting commissions.fees payable.
Simultaneously with the closing of the IPO, we consummated the Private Placementprivate placement of 990,000 Private Placement Sharesprivate placement shares at a price of $10.00 per Private Placement Shareprivate placement share to the Sponsor,sponsor, generating proceeds of $9,900,000.
18
Table of Contents
Upon the closing of the IPO and the Private Placement,private placement, the $345,000,000 ($10.00 per share) of the net proceeds offrom the Initial Public OfferingIPO and certain of the proceeds of the Private Placement was heldprivate placement were placed in a Trust Account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 180 days or less or in money market funds meeting certain conditions under Rule
Rule 2a-7
promulgated under the Investment Company Act whichthat invest only in direct U.S. government treasury obligations, as determined by us, until the earlier of: (i) the completion of a Business Combinationbusiness combination and (ii) the distribution of the Trust Account.
If we are unable to complete a Business Combination within 24business combination by March 8, 2023 (24 months from the closing of the Initial Public Offering, MarchIPO), or June 8, 2023 or 27(27 months from the closing of this offering, June 8, 2023,the IPO), if we have executed a letter of intent, agreement in principle or definitive agreement for an initial Business Combination within 24 months from the closing of this offering (the “Combination Period”),business combination by March 8, 2023, and our stockholders have not amended the Certificatecertificate of Incorporationincorporation to extend such Combination Period,period, we will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but no more than ten business days thereafter subject to lawfully available funds therefor, redeem the Public Shares,public shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay our taxes as well as expenses relating to the administration of the Trust Account (less up to $100,000 of interest to pay dissolution expenses) divided by the number of the then outstanding Public Shares,public shares, which redemption will completely extinguish Public Stockholders’public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law; and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the board of directors, liquidate and dissolve, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.
19
On June 9, 2021, the Companywe entered into an Agreement and Plan of Merger (the “Merger Agreement”)agreement for a proposed initial business combination with Valo Health, Inc., a Delaware corporation (“Valo”), Valo Health, LLC, a Delaware limited liabilitytechnology company (“Valo Holdco”using human-centric data and togetherartificial intelligence (AI) powered computation to transform the drug discovery and development process. Concurrently with Valo, the “Valo Parties”) and Killington Merger Sub Inc., a Delaware corporation and a direct wholly-owned subsidiary of the Company (“Merger Sub”). On June 9, 2021, concurrently with the execution of the Merger Agreement, the Companysuch an agreement, we also entered into subscription agreements (the “PIPE I Subscription Agreements”) with certain investors (collectively, the “PIPE I Investors”), pursuant to, and on the terms and subject to the conditions of which, the PIPE I Investors have collectively subscribed for 16,855,000 shares of Class A common stock par value $0.0001 per share (“KVSA Common Stock”), for an aggregate purchase price equal to $168,550,000 (the “PIPE I Investment”). On July 30, 2021, the Companywe entered into additional subscription agreements (the “PIPE II Subscription Agreements”) with certain investors (collectively, the “PIPE II Investors”), pursuant to, and on the terms and subject to the conditions of which, the PIPE II Investors have collectively subscribed for an additional 3,231,250 shares of KVSA Common Stock for an aggregate purchase price equal to $32,312,500 (the “PIPE II Investment”).
On November 15, 2021, we and Valo Health mutually agreed to terminate the proposed initial business combination based on market conditions, particularly in the biotechnology area. As such, we continue to search for a potential initial business combination target. The PIPE I Investment and PIPE II Investment are each expected to be consummated substantially concurrently withwere also both terminated upon the Closing.
Liquidity and Capital Resources
As of March 31, 2021, the Company had $1,546,860 in its operating bank account, $345,000,000 in cash held in the Trust Account to be used for a Business Combination or to repurchase or redeem its common stock in connection therewith and working capital of $1,530,142.
If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, suspending the pursuit of a Business Combination. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.
As a resulttermination of the above, in connectionproposed initial business combination with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”)
2014-15,
“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the liquidity condition and date for mandatory liquidation and dissolution raise substantial doubt about the Company’s ability to continue as a going concern through approximately one year from the date these condensed financial statements were issued. These condensed financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.
Prior to the consummation of the IPO, the Company’s liquidity needs have been satisfied through receipt of a $25,000 capital contribution from the Sponsor in exchange for the issuance of the Founder Shares to the Sponsor, and a $300,000 promissory note payable to the Sponsor. Subsequent to the consummation of the Initial Public Offering, the Company received the net proceeds not held in the Trust Account of $3,000,000.
19
Table of Contents
In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest.Valo Health.
Results of Operations and Known Trends or Future Events
We have neither engaged in any operations (other than searching for a Business Combinationbusiness combination after our Initial Public Offering)IPO) nor generated any revenues to date. Our only activities from January 15, 2021 (inception) through March 31, 20212022 were organizational activities and those necessary to prepare for the Initial Public Offering, described below.IPO and the proposed initial business combination. We do not expect to generate any operating revenues until after the completion of our Business Combination.business combination. We expect to generate
non-operating
income in the form of interest income on marketable securities held after the Initial Public Offering.IPO. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended March 31, 2022, we had a loss from operations of $421,195, which consisted of $371,195 of general and administrative expenses and $50,000 in franchise tax expense. We also incurred a $150,000 gain on the change in fair value of derivative liabilities, and a $28,158 gain on marketable securities held in Trust Account, resulting in a net loss of $243,037 for the three months ended March 31, 2022.
For the period from January 15, 2021 (inception) through March 31, 2021, we had a loss from operations of $196,558, which consisted of $30,000 in formation costs, $116,558 in general and administrative expenses, and $50,000 in franchise tax expenses. We also incurred $12,137,500 in financing expenses on the Class K Founder Shares derivative classified instruments, and an unrealized gain oninstrument, offset by the change in fair value of derivative liabilities of $9,000,000, resulting in an overalla net loss of $3,334,058 for the period from January 15, 2021 (inception) through March 31, 2021.
Off-BalanceLiquidity and Capital Resources
Sheet Arrangements
We did not have any
off-balance
sheet arrangements asAs of March 31, 2021.2022, the Company had $22,668 in its operating bank account, $657,731 in prepaid expenses, $345,045,187 in marketable securities held in the Trust Account to be used for a business combination or to repurchase or redeem its common stock in connection therewith and a working capital deficit of $3,647,394. As of March 31, 2022, $28,158 of the amount on deposit in the Trust Account represented interest income, which is available for payment of franchise taxes and expenses in connection with the liquidation of the Trust Account. In addition, the Working Capital Loan and advances from related parties are available to the Company to fund operations.
If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, suspending the pursuit of a business combination. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.
20
As a result of the above, in connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”)
2014-15,
“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the liquidity conditions raise substantial doubt about the Company’s ability to continue as a going concern through approximately one year from the date of filing. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.
Contractual Obligations
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities.
The underwriters are entitled to a deferred fee of $0.35 per Public Share,public share, or $12,075,000 in the aggregate. The deferred fee will be waived by the underwriters in the event that the Company does not complete a Business Combination,business combination, subject to the terms of the underwriting agreement.
On March 3, 2021, we entered into a forward purchaseforward-purchase agreement pursuant to which the sponsor (together with any permitted transferees under the forward purchaseforward-purchase agreement, the “Khosla Entities”) have agreed to purchase an aggregate of up to 2,500,000 forward purchaseforward-purchase shares for $10.00 per share, or an aggregate maximum amount of $25,000,000, in a private placement that will close simultaneously with the closing of the initial Business Combination.business combination. The Khosla Entities will purchase a number of forward-purchase shares that will result in gross proceeds to us necessary to enable us to consummate our initial Business Combinationbusiness combination and pay related fees and expenses, after first applying amounts available to us from the Trust Account (after paying the deferred underwriting discountfees payable and giving effect to any redemptions of Public Shares) and any other financing source obtained by us for such purpose at or prior to the consummation of our initial Business Combination,business combination, plus any additional amounts mutually agreed by us and the Khosla Entities to be retained by the post-Business Combinationpost-business combination company for working capital or other purposes. The Khosla Entities’ obligation to purchase forward-purchase shares will, among other things, be conditioned on the Business Combinationbusiness combination (including the target assets or business, and the terms of the Business Combination)business combination) being reasonably acceptable to the Khosla Entities and on a requirement that such initial Business Combinationbusiness combination is approved by a unanimous vote of our board of directors. In determining whether a target is reasonably acceptable to the Khosla Entities, we expect that the Khosla Entities would consider many of the same criteria as we will consider but will also consider whether the investment is an appropriate investment for the Khosla Entities.
Critical Accounting Policies
The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have not identified any critical accounting policies other than the following.
Class K Founder Shares Derivative Liabilities
20Please refer to additional information in filed 10- K for the fiscal year ended December 31, 2021 within Financial Statements Note 4 and Note 7.
21
Table of Contents
Class K Founder Common Stock
Class K common stock was accounted for as a liability in accordance with ASC Topic 815 and presented as derivative liability on the accompanying March 31, 2021, balance sheet. The derivative liability was measured at fair value at inception and on a recurring basis, which changes in fair value presented within change in fair value of derivative liability in the statements of operations. In order to capture the market conditions associated with the Class K common stock liability, the Company applied an approach that incorporated a Monte Carlo simulation, which involved random iterations of future stock-price paths over the contractual life of the Class K common stock. Based on assumptions regarding potential changes in control of the Company, and the probability distribution of outcomes, the payoff to the holder was determined based on the achievement of the various market thresholds within each simulated path. The present value of the payoff in each simulated trial is calculated, and the fair value of the liability is determined by taking the average of all present values.
The inputs used as of March 31, 2021 were as follow: risk free rate: 1.77%; term to business combination: 0.8 years; expected volatility: 15.5% and stock price: $10.10.
Recent accounting standards
Accounting Standards
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our unaudited condensed financial statements.
21
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are a smaller reporting company as defined by
Rule 12b-2
Table of Contentsthe Exchange Act and are not required to provide the information otherwise required under this item.
Item 3.
Item 4. Controls and Procedures
Quantitative and Qualitative Disclosures About Market Risk
As of March 31, 2021, we were not subject to any market or interest rate risk. Following the consummation of our Initial Public Offering, the net proceeds of our Initial Public Offering, including amounts in the Trust Account, have been invested in U.S. government treasury bills, notes or bonds with a maturity of 180 days or less or in certain money market funds that invest solely in U.S. treasuries. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.
Item 4.
Controls and Procedures
Evaluation of Disclosure Controlsdisclosure controls and Proceduresprocedures
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended March 31, 2021,2022, as such term is defined in Rules
13a-15(e)
and
15d-15(e)
under the Exchange Act.
Based on this evaluation, our principal executive officer and principal financial and accounting officer have concluded that during the period covered by this report, our disclosure controls and procedures were not effective due to material weaknesses in internal controls over financial reporting related to the inaccurate accounting. Management identified errors in its historical financial statements related to the accounting for the Class A common stock and the Class K Founder Shares.founder shares. Because the Class A common stock issued in the Initial Public OfferingIPO can be redeemed or become redeemable subject to the occurrence of future events considered outside of the Company’s control, the Company should have classified all of these redeemable shares in temporary equity and remeasured these redeemable shares to their redemption value (i.e., $10.00 per share) as of the end of the first reporting period after the date of the Company’s Initial Public Offering.IPO. Management also concluded that it incorrectly accounted for the Class K Founder Sharesfounder shares as permanent equity versus a derivative liability.
To address these material weaknesses, management has devoted, and plans to continue to devote, significant effort and resources to the remediation and improvement of its internal control over financial reporting and to provide processes and controls over the internal communications within the Company, financial advisors and independent registered public accounting firm. While we have processes to identify and appropriately apply applicable accounting requirements, we plan to enhance these processes to better evaluate our research and understanding of the nuances of the complex accounting standards that apply to our financial statements. We plan to include providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects. Other than this issue, our disclosure controls and procedures were effective at a reasonable assurance level and, accordingly, provided reasonable assurance that the information required to be disclosed by us in reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.
Changes in Internal Controlinternal control over Financial Reportingfinancial reporting
During the quarter ended March 31, 2021,2022, there has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting, as the circumstances that led to the material weaknessweaknesses described above had not yet been identified. We are in the process of implementing changes to our internal control over financial reporting to remediate such material weaknesses, as more fully described above. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.
PART II - OTHER INFORMATION
22
PART
II-OTHER
INFORMATION
Item 1.
Item 1. Legal Proceedings.
None.
Item 1A.
Item 1A. Risk Factors.
Factors that could cause our actual results to differ materially from those in this report include the risk factors described in Part I, Item 1A “Risk Factors” in our final prospectus filed withAnnual Report on Form
10-K
for the SEC on March 4,year ended December 31, 2021. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our final prospectus filed withAnnual Report on Form
10-K
for the SEC.year ended December 31, 2021.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
There were no sales of unregistered securities during the three months ended March 31, 2022.
22
Table of Contents
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds.
On March 8, 2021, we consummated the Initial Public Offering of 34,500,000 Public Shares, including 4,500,000 Public Shares sold pursuant to the full exercise of the underwriters’ option to purchase additional Public Shares to cover over-allotments. The Public Shares were sold at an offering price of $10.00 per share, generating total gross proceeds of $345,000,000. Goldman Sachs & Co. LLC and Piper Sandler & Co. acted as joint book-running managers for the offering. The securities in the offering were registered under the Securities Act on a registration statement on Form
S-1
(No.
333-253096).
The Securities and Exchange Commission declared the registration statement effective on March 3, 2021.
Simultaneously with the consummation of the Initial Public Offering and the full exercise of the over-allotment option, we consummated the private placement of an aggregate of 990,000 Private Placement Shares at a price of $10.00 per Private Placement Share, generating total proceeds of $9,900,000. The issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
The Private Placement Shares are identical to the Public Shares sold in the Initial Public Offering, except that the Private Placement Shares are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions.
Of the gross proceeds received from the Initial Public Offering, the full exercise of the over-allotment option and the sale of the Private Placement Shares, $345,000,000 was placed in the Trust Account.
We paid a total of $6,900,000 in underwriting discounts and commissions and $685,260 for other offering costs related to the Initial Public Offering. In addition, the underwriters agreed to defer $12,075,000 in underwriting discounts and commissions.
For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Quarterly Report.
Item 3.
3. Defaults Upon Senior Securities.
None.
Item 4.
Item 4. Mine Safety Disclosures.
Not Applicable.
Item 5.
Item 5. Other Information.
None.
Item 6.
Item 6. Exhibits
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form
10-Q.
 
      
Incorporated by Reference
   
Filed/

Furnished

Herewith
 
Exhibit
Number
  
Exhibit Description
  
Form
   
File No.
   
Exhibit
   
Filing
Date
 
3.1  Second Amended and Restated Certificate of Incorporation, dated March 4, 2021   8-K    001-40131    3.1    3/9/21   
3.3  Bylaws   S-1    333-253096    3.3    2/12/21   
4.1  Specimen Class A Common Stock Certificate   S-1    333-253096    4.1    2/12/21   
23
Incorporated by Reference
Filed/

Furnished

Herewith
No.Exhibit
Number
  
Exhibit Description of Exhibit
    1.1  Underwriting Agreement, dated March 23, 2021, between the Company and Citigroup Global Markets Inc. and Goldman Sachs & Co. LLC, as representatives of the several underwriters. (1)
Form
File No.
Exhibit
Filing
Date
    3.1Amended and Restated Certificate of Incorporation, dated March 24, 2021. (1)
  10.1Investment Management Trust Agreement, dated March 23, 2021, between the Company and Continental Stock Transfer & Trust Company, as trustee. (1)
  10.2Registration Rights Agreement, dated March 23, 2021, among the Company and certain security holders named therein. (1)
  10.3Private Placement Shares Purchase Agreement, dated March 23, 2021, between the Company and the Sponsor. (1)
  10.4Forward Purchase Agreement, dated March 23, 2021, among the Company and the Sponsor. (1)
  10.5Letter Agreement, dated March 23, 2021, among the Company, the Sponsor, Vinod Khosla, Samir Kaul, Peter Buckland, Anita Sands, Enrico Gaglioti and Dmitri Shklovsky. (1)
  10.6Form of Indemnity Agreement, dated March 23, 2021, between the Company and each of its officers and directors. (1)
  31.1*31.1  Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
23
Table of Contents
No.
Description of Exhibit
  31.2*31.2  Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
  32.1**32.1  Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes- Oxley Act of 2002**
  32.2**32.2  Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes- Oxley Act of 2002**
101.INS*101.INS  Inline XBRL Instance Document*
101.CAL*101.SCHInline XBRL Taxonomy Extension Schema Document*
101.CAL  Inline XBRL Taxonomy Extension Calculation Linkbase Document*
101.SCH*Inline XBRL Taxonomy Extension Schema Document
101.DEF*101.DEF  Inline XBRL Taxonomy Extension Definition Linkbase Document*
101.LAB*101.LAB  Inline XBRL Taxonomy Extension LabelsLabel Linkbase Document*
101.PRE*101.PRE  Inline XBRL Taxonomy Extension Presentation Linkbase Document*
104*104  Cover Page Interactive Data fileFile (formatted as inline XBRL)Inline XBRL and contained in Exhibit 101)*
 
*
Filed herewith.
**
Furnished.Furnished herewith.
(1) Previously filed as an exhibit to our Current Report on Form
8-K
filed on March 30, 2021 and incorporated by reference herein.
 
24
Table of Contents
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
  
KHOSLA VENTURES ACQUISITION CO.
Date: SeptemberMay 13, 20212022  By: 
/s/ Peter Buckland
  Name: Peter Buckland
  Title: Chief Financial Officer
25